Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-02 · accession 0001209191-21-054896 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-03 | 2021-09-02 | PBYI | NOUGUES MAXIMO F | CFO | S - Sale | $7.51 | -155 | 67.8K | -0.2% | -$1,164 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-09-02 | S | D | 155 | $7.51 | 67,754 | D | — | — |